Split Fed. Circ. Won't Restore 4 Narcan Patents
By Dani Kass ( February 10, 2022, 4:32 PM EST) -- Generic drug giant Teva scored a win at the Federal Circuit on Thursday when a divided panel stood by a New Jersey federal judge's invalidation of claims in four patents covering Adapt Pharma's opioid overdose medication Narcan....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.